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,‘;,: Gut ex!fwts that contain ~uca~~~j~ ~~u~~ 
.reacwiti cc_u j have ~~XTI;~OW~ t0 pan gjlyc0 
-&n$y#~ -( 11 and @ulinhgeni;: [ 2] P.ctMty. 1 t is, how- 
e~ei,~u&nd~ whether these extracts exer: their ef- 
-f&#s titigh thb tie receptoi sit.2 as pancrtiWic 
~gluc&;z 21 gluca~on-sensitiv’e’tiqe: tissues, &%ough 
.p_r+c@i ikll;o;t sug@s thatGlJcont.aining extracts 
from po&te gut interact.with pancreatic giticagon . - 
rece&k h fi cdil membranes 131. We found that GLJ- 
~n~~f~~~~ pie-d from porcine gut inter- 
&t with-the’ pankatfc gh&gon receptors and stimu- 
late the adenylate cyclase in liver pie -X-W -nembranes, 
indicating that a common receptor sitti IS involved in 
the ~ter~ti~ of pancreatic and ~~-~ucago~ with 
the liver. Furtclermqt-e, our data indicate the existence 
0,F 8 specific receptor site for the pancreatic glucagon. 
Z Materialsand methods 
Porcine jejune-Aeons were resected i~ed~tety after 
slaughter. Extracts of the muccsa obtained by a modiiT 
cation (SW legend to fig. t) of the Kenny procedure [441 
were fractionated on Bio Gel P IO as indicated in fig. I. 
Fig. 2. Displacement of i “‘ljpancreatic $ucagon from its liver rec+zptors by unlabeled pancreatic glucagon and by fractions A and 
B [see fig_ I) of gut glucagon, Membranes iO.2,0.3 mg protein/ml incubation mcdium).were incubated for 30 mir, at 30”, pH 7.5; 
in Krebs Ringer phosphate buffer containin g 10 rnX1 Tris, 2.4% CW/V) bovine serum albumin [Fraction V, Penre?r), 2 O&W of 
KS&rein inhibitor (Zvmofrcn, SpecIzMml as an inhibitor of glucagon degradation, 20-30 pM OT l”‘I Jpancreatic glucago,n and 
v~iaus 3nlounts of unfabc1e.d peptides as indicated. The membrane-bound iLz5 
111, 121, The inicinl binding of 1 “‘I . 
I]glucagon was isolated as previously’described 
1; Iucwon is the percentage of the ^ iotcll radioactivity bound to the membranes in the absence 
of or&b&cd hormone_ This perc_xntage \~~about 3s. Before use, the lyophilized chromatographic fractions had bren.dissotsed 
ti 75 m&E Tris-HCI, pH 7.5, and diafyzed over~igbt against the wmu buffer. 
The protein cmtents were assqed ‘oy the Lowry meth- 
cd ISI. GLI was evafuated in each iyupltitized fraction 
by glucagon radioimmunoassay j6, 71 using antisera 
that cross react with gut GLI; similar results were ob- 
tained with three such antisera. In all of four fractiort- 
ations of the jejuneilea] extracts, the distribution of 
rhe GLi conformed to the pattern depicted in fig. 1: 
GLi was recovered as a major peak with a maximum 
close to the insulin market (fraction .A) and the remain- 
ing immunorsactivity was &ted $most coiacidently 
with tke paricrcatic glucagon marker (fraction B). 
Purified plasma membranes (step 11, [S]) were 1 
prepared from rat livers according to Neville 181). 
P6rk pancreatic mono [*= Ilglucagon was prepared as 
desrri5ed pTeVio&~ 591 z&?gs simi)ar r3I!ztha* tii3 t&& 
emplqed hs t!Ae preparatisn af 3nonoiodoi.inalin [ lo]_ 
Experiments measuring the binding of glucagon to its 
specGc receptors <n liver pIasxna membranes were per- 
formed as described elsewhere [I i, 121 with the modi- 
fications indicated in the l&end to fig- 2. This method 
makes it possible to measure glucagon-receptor inter- 
action at concentrations of the hormone as low as 
O-01--1.0 r&f. The adenylate cyciase activit-f was mea- 
sued b>- radioimmunoassay of cyclic AMP [ 13J_ This 
method permits the spe&ic measurement of thz cyclic 
_&&II? produced in quantities as low as I pmale_ 
3. ELesaslts a&l discussion 
Both fractions A and 5 inhibited the specific bind- 
ing of [I*’ llpancreatic glucagon to Ever membranes 
(fig_ 2). In sharp contrast, huge amounts of synthetic 
gastrin*.as well as highly purified xeecretin? and choIc- 
cystok~ira-pancreozymin~ (OX-PZ) failed to inter- 
Cere With ?he binding of pancreatic glucagon (fig. 2j. 
Similarly, nr, observed with the 
%5z33DC&~~ &3%&z& $EC&qD~J~& qVu?>&%.-$53lx!x% 
tent; were almost as effective as equivalent amounts 
of unlabeled pancreatic glucagoti in dis~Iacing the 
[‘251]pamxeatic glucagon from its receptors_ Fractiofi 
A also interfered with the binding of pancreatic 
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Fig. 4_ Stimularion of adenyfatc cycbse by pancreatic gI!~ag~n 
and by fractions A and B in liver phsma membranes. The incu- 
batior, sdution cw~taineJ, in n 25@ pl final v&unC, 0-S mht 
_A??, 20 mM crcidine phosphstc, f m&ml phosplwxreatinc 
Mnase, 25 mBf theophylEne, 5 ITIM hlg CL, 20. mh! TrikHCi’ 
@1-i 7.5). 0.4% (w/v] bovine serum albumin, ,1 mM EDTA and 
I00 &ml bacitracin. Reactions were started in the absence or 
in the presecce of h~~one(s~ as indicated, with addition of 
enzyme at about 50 ~g of membrane protein, i.e. 0.2 m&ml 
fiial cone_ incubations were performed for 15 min at 30°. The 
cyclic AMP produced was measurzd by r~dio:immunoassay 113j. 
i&h pokt is the mean f SE aftripficate determinations- 
the effects observed tjith tur fractions since these 
hormones were irleffective in displacing the [rx I]- 
ghzcagon as ~eif as in stimulating the adenytate q&se_ 
br vim studies with direct mexurement of ghrc- 
From data shown in i-is. 2 an& 3, equivahxxccs (in &of pan- 
creatic glucagon) were determined for booth frzxkns of gu t 
&xcagon by comparirq their ability in disphcing t’ 2fE jpan- 
creatic ghrcagon from receptors (center column) and iu stim 
ulrtting a~enylate cyclase (right column), to the abilitjf of 
pancreatic @wagon. The left column indicates the correspoad- 
ing GLI confent of each fraction. 
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agon-receptor interactions such as those reported here 
appear to be very important in investigaZing further the 
biochemical relationships between the pancreatic tind 
the gut gkagms. 
We thank Dr. J. Roth for his helpfuf advice; Dns_ 
J.E. Jbrpes, V. Mutt, J. Plcssier and I_ Simon for their 
gifts in hormones; N. Grenier and D, Wui Bon Hoa for 
their excdlent xechnicd assistance, 
